These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


552 related items for PubMed ID: 19211218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury.
    Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M.
    Crit Care Med; 2003 Mar; 31(3):939-45. PubMed ID: 12627009
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tau proteins in serum predict outcome after severe traumatic brain injury.
    Liliang PC, Liang CL, Weng HC, Lu K, Wang KW, Chen HJ, Chuang JH.
    J Surg Res; 2010 May 15; 160(2):302-7. PubMed ID: 19345376
    [Abstract] [Full Text] [Related]

  • 8. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M.
    Acta Neurochir Suppl; 2010 May 15; 106():247-50. PubMed ID: 19812958
    [Abstract] [Full Text] [Related]

  • 9. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
    Pfeifer R, Börner A, Krack A, Sigusch HH, Surber R, Figulla HR.
    Resuscitation; 2005 Apr 15; 65(1):49-55. PubMed ID: 15797275
    [Abstract] [Full Text] [Related]

  • 10. Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study.
    Ghori KA, Harmon DC, Elashaal A, Butler M, Walsh F, O'Sullivan MG, Shorten GD.
    Crit Care Resusc; 2007 Jun 15; 9(2):166-71. PubMed ID: 17536986
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
    Nylén K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, Nellgård B, Rosengren L.
    Acta Neurochir (Wien); 2008 Mar 15; 150(3):221-7; discussion 227. PubMed ID: 18193148
    [Abstract] [Full Text] [Related]

  • 12. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
    Sawauchi S, Taya K, Murakami S, Ishi T, Ohtsuka T, Kato N, Kaku S, Tanaka T, Morooka S, Yuhki K, Urashima M, Abe T.
    No Shinkei Geka; 2005 Nov 15; 33(11):1073-80. PubMed ID: 16277220
    [Abstract] [Full Text] [Related]

  • 13. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.
    Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U.
    Acta Neurol Scand; 2010 Mar 15; 121(3):178-85. PubMed ID: 19804476
    [Abstract] [Full Text] [Related]

  • 14. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, Fujita M, Izumi T, Maekawa T.
    J Trauma; 2010 Jul 15; 69(1):104-9. PubMed ID: 20093985
    [Abstract] [Full Text] [Related]

  • 15. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.
    J Neurosurg; 2005 Jul 15; 103(1 Suppl):61-8. PubMed ID: 16122007
    [Abstract] [Full Text] [Related]

  • 16. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
    Nylén K, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgård B, Rosengren L.
    J Neurol Sci; 2006 Jan 15; 240(1-2):85-91. PubMed ID: 16266720
    [Abstract] [Full Text] [Related]

  • 17. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.
    Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, Rhind S, Tien HC, Baker AJ.
    J Trauma; 2011 Nov 15; 71(5 Suppl 1):S478-86. PubMed ID: 22072007
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury.
    Kirchhoff C, Buhmann S, Braunstein V, Leidel BA, Vogel T, Kreimeier U, Mutschler W, Biberthaler P.
    Eur J Med Res; 2008 Nov 24; 13(11):511-6. PubMed ID: 19073387
    [Abstract] [Full Text] [Related]

  • 19. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.
    Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.
    Clin Lab; 2011 Nov 24; 57(7-8):587-97. PubMed ID: 21888023
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of serum S100B protein in critically ill patients without brain injury.
    Routsi C, Stamataki E, Nanas S, Psachoulia C, Stathopoulos A, Koroneos A, Zervou M, Jullien G, Roussos C.
    Shock; 2006 Jul 24; 26(1):20-4. PubMed ID: 16783193
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.